H5N1 Testing Program Coming from CAP This Fall
While the current risk to humans of H5N1 remains low, CAP is launching a testing program to help labs better detect and subtype the virus.
While the current risk to humans of H5N1 remains low, CAP is launching a testing program to help labs better detect and subtype the virus.
Alveo Technologies secured a CDC agreement to develop a test for detecting and differentiating between Influenza A, B, and A/H5.
ID-FISH Technology's new test for the detection of IgG antibodies against Borrelia-causing Lyme disease has received FDA clearance.
A study detailed a new Zika virus-specific synthetic molecule that effectively distinguishes Zika from related dengue virus infections.
Read MoreGeorge Mason University researchers have been awarded over $1 million to develop a urine-based Lyme disease test.
Read MoreThe FDA granted EUA for Labcorp’s Mpox PCR Test Home Collection Kit, facilitating the early detection and management of mpox infections.
Read MoreResearchers developed a rapid, accurate test for diagnosing malaria that is significantly faster and easier to use than traditional tests.
Read MoreA study showcased the application of Flongle sequencing as a cost-efficient and rapid method to detect the zoonotic pathogen.
Read MorePicodya has developed a scalable solution that is being used by the NIH to find Disease X and stop the next pandemic in its tracks.
Read MoreA new study has revealed disparities in the diagnosis and treatment of Lyme disease between Black and White patients with the condition.
Read MoreA pilot study demonstrated the importance of self-sampling in diagnosing asymptomatic or atypical cases of mpox.
Read MoreCurrent diagnostic methods can vastly overestimate the rates that malaria parasites are multiplying in an infected person’s blood.
Read MoreA rapid test for mpox has been developed that can detect the virus within minutes, without the use of any high-end instrumental techniques.
Read MoreNoze received a grant of $1 million to build a breathalyzer, powered by its platform, to detect breath biomarkers (VOCs).
Read MoreCue Health has received EUA from the U.S. Food and Drug Administration (FDA) for its molecular test to detect the mpox (monkeypox) virus.
Read MoreThe test kit is for use in laboratory settings and can help healthcare professionals accurately identify an Avian Influenza A Virus infection.
Read MoreThe FDA issued an emergency use authorization for the Cepheid Xpert Mpox (monkeypox) test for use in a point-of-care setting.
Read MoreA new study identified Raman spectroscopy as a promising diagnostic approach for Lyme disease, according to the Bay Area Lyme Foundation.
Read More